Anthropic posted a San Francisco bench-science job paying $65,000–$85,000 — below HUD's low-income threshold for the city — six weeks after closing a $65 billion Series H at a $965 billion valuation.

Anthropic, which closed a $65 billion Series H round in late May at a $965 billion post-money valuation, is currently recruiting a Research Associate for its new biology team in San Francisco at an annual salary of $65,000 to $85,000, according to an active posting on the company's Greenhouse job board.

The role — a fully hands-on bench position requiring a bachelor's degree in molecular biology or biochemistry, proficiency in PCR, cell culture, and molecular cloning — sits at the floor of what San Francisco considers survivable. The federal Department of Housing and Urban Development classifies $109,000 as the low-income threshold for a single person in the city; the average rent for a one-bedroom apartment hit $3,827 per month in 2026, per Briefs.co. At $65,000 gross, a Research Associate would net roughly $4,200 a month after taxes — leaving around $400 for everything beyond rent.

The gap between that number and the rest of Anthropic's compensation is stark. The company's median total compensation runs approximately $420,000 company-wide, rising to around $750,000 for software engineers, per prior reporting via HTX Insights. The $65k floor is not a quirk of equity structure: the posting lists no equity component.

The Series H — co-led by Altimeter Capital, Dragoneer, Greenoaks, and Sequoia Capital, with Amazon ($5B) and Google ($10B) as major strategic participants — closed May 28, according to Anthropic's announcement. Anthropic PBC has filed no Form D directly with the SEC; all traceable SEC filings are from third-party SPVs. The company has also made a confidential IPO filing, with no share count or pricing yet determined.

None of this is strictly unusual: bench research associate roles at biotech and pharma companies in the Bay Area commonly pay in this range, and this is not a software engineering job. What's notable is the context — a near-trillion-dollar AI company standing up a new life sciences team, pitching the role as "a rare opportunity to help define how a frontier AI company does biology," at a salary that, in San Francisco in 2026, leaves the candidate essentially cost-burdened from day one. The posting is still live as of this writing.